Chemical Structure
220127-57-1
≥98% (HPLC)
C₂₉H₃₁N₇O·CH₄O₃S
589.7 g/mol
Imatinib mesylate is a tyrosine kinase inhibitor used in the treatment of multiple cancers, most notably Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML).
Get pricing and availability information for this product.